Z-1796-2023 Class I Ongoing
FDA device recall Z-1796-2023 was initiated by Medtronic Inc., Cardiac Rhythm And Heart Failure (CRHF) on May 10, 2023 and is designated Class I. Reason for recall: There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy… The recall status is ongoing. Affected quantity: 4 units.
Recall details
- Product Type
- Devices
- Report Date
- Jun 28, 2023
- Initiation Date
- May 10, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4 units
Product description
ICD-VR DVBB1D4 EVERA XT DF4 US, Model Number DVBB1D4; Implantable Cardioverter Defibrillators
Reason for recall
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) manufactured with a specific (glassed) feedthrough, including currently available ICDs and CRT-Ds.
Distribution pattern
US Nationwide - Worldwide Distribution
Code information
GTIN 00643169720435, Lot Serial Number: BWH224619H, BWH224621H, BWH224620H, BWH224623H
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1796-2023
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026